Summary of findings for the main comparison. Adjunct cognitive behavioural therapy versus adjunct supportive psychotherapy.
Adjunct cognitive behavioural therapy compared to adjunct supportive psychotherapy (both with standard medication for most patients) for delusional disorder | ||||||
Patient or population: patients with delusional disorder Settings: community Intervention: cognitive behavioural therapy Comparison: attention (both with standard medication) | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
Attention (mainly with standard medication) | Cognitive behavioural therapy(mainly with standard medication) | |||||
Global state: Clinically significant improvement | See comment | No study reported this outcome | ||||
Mental state: Delusions ‐ clinically significant improvement | See comment | MADS reported in the single relevant small study, but not a clinical scale and no report of symptomatic improvement on delusions | ||||
Mental state: Depression BDI Follow‐up: 6 months | CBT ‐ average score 12.0 (SD 14.4, N = 11) Attention 'placebo' ‐ average score 18.3 (SD 7.8, N = 6) |
Not estimable | 17 (1 study) | ⊕⊕⊝⊝ low1,3 | Data skewed | |
Mental state:
Anxiety BAI Follow‐up: 6 months |
CBT ‐ average score 16.1 (SD 14.6, N = 11) Attention 'placebo' ‐ average score 14.0 (SD 14.2, N = 6) |
Not estimable | 17 (1 study) | ⊕⊕⊝⊝ low1,3 | Data skewed | |
Service use: Admission | See comment | No study reported this outcome | ||||
Social function: Self worth ‐ average score Social Self‐Esteem Inventory Follow‐up: 6 months | The mean social functioning: self worth average score in the intervention groups was 30.5 higher (7.51 to 53.49 higher) | 17 (1 study) | ⊕⊝⊝⊝ very low1,2,3 | |||
Adverse event: Leaving the study early Follow‐up: 6 months | Low | RR 0.17 (0.02 to 1.18) | 24 (1 study) | ⊕⊕⊕⊝ moderate4 | ||
100 per 1000 | 17 per 1000 (2 to 118) | |||||
Moderate | ||||||
300 per 1000 | 51 per 1000 (6 to 354) | |||||
High | ||||||
500 per 1000 | 85 per 1000 (10 to 590) | |||||
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory;CBT: cognitive behavioural therapy; CI: confidence interval; MADS: Maudsley Assessment of Delusions Schedule; RR: risk ratio; SD: standard deviation | ||||||
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |
1Risk of bias: rated 'serious' ‐ unblinded for subjective outcome, poor reporting for those who left early. 2Indirectness: rated 'very serious' ‐ measure reported self worth rather than social functioning. 3Imprecision: rated 'serious' ‐ small trial, wide confidence intervals. 4Indirectness: rated 'very serious' ‐ leaving study may not be adverse effect or event. Reasons for attrition not reported.